ClinicalTrials.gg
Not yet recruitingNCT07871136FIQS DIUpdated Oct 13, 2026

FIQS Dissemination and Implementation

An interventional study of Text-Only Enrollment Strategy and Text Plus In-Person Enrollment Strategy in Inpatient Experience Survey Administration, Inpatient Experience Survey Response and Inpatient Pediatric Care, sponsored by University of California, San Francisco. Not yet recruiting at 8 sites in United States. Open to participants aged 13 Years and older. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Health services research

Updated Oct 13, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
21,800
Allocation
Randomized
Ages
13 Years and older
Sex
All
01

Study summary

This study is testing Family Input for Quality and Safety (FIQS), a mobile-based survey tool that allows hospitalized children's families and adolescent patients to report safety concerns in real-time by responding to a text message link on their mobile phone. The main questions it aims to answer are:

  1. Does the way families are invited to use the safety reporting survey (text-only invitation versus text plus brief in-person orientation) affect how many families participate and report safety concerns?
  2. Does sharing safety reports anonymously versus with patient identifiers (for example, the patient name or room number) affect how often families report concerns and how hospitals respond?
  3. What barriers and supports help hospitals successfully use the reports from the survey to make safety improvements without extensive/dedicated research infrastructure?

Researchers will compare different enrollment approaches and anonymous versus identified reporting across multiple children's hospitals to see which methods work best for engagement with the FIQS tool. Participants will:

  • Receive automated text message invitations when their child is admitted to participating hospital units
  • Be randomly assigned to receive either text-only invitation or an additional brief in-person orientation
  • Use a mobile-responsive survey to report safety concerns during their hospital stay through daily text prompts
  • Be randomly assigned to have their reports shared either anonymously or with identification to help hospital staff follow up
  • Participate during hospitalization while hospitals learn to integrate family safety reports into their quality improvement efforts
02

Conditions studied

  • Inpatient Experience Survey Administration
  • Inpatient Experience Survey Response
  • Inpatient Pediatric Care
  • Inpatient Pediatric Engagement and Shared Decision-Making

Keywords

  • Family-centered safety surveillance
  • Pediatric hospital quality improvement
  • Patient engagement technology
  • Pediatric patient safety
  • Pediatric inpatient quality
03

In context

Lead sponsor

University of California, San Francisco is the lead sponsor of 2,164 studies on the registry; 368 are open to participants now.

Of its 267 completed or terminated interventional studies of FDA-regulated products, 199 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Family members or caregivers of patients (aged 0 to 21 years) admitted to participating hospital units
  • Patients aged 13 years and older admitted to participating hospital units
  • English or Spanish speakers
  • Patient or parent/guardian owns a mobile phone
  • Patient or parent/guardian present during hospitalization

Exclusion criteria

Exclusion Criteria:

  • Patients or parents/guardians who are non-English and non-Spanish speakers
  • Patients or parents/guardians who do not own a mobile phone
  • Patients admitted under sensitive services
  • Patients who are in the foster care system
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Outcomes assessor)
Enrollment
21,800 participants (estimated)

Study arms

  • Active comparator
    Aim 1: Text-Only Enrollment

    Family members of hospitalized children and adolescent patients (\>12y.o.) receive automated text message invitations to participate in Family Input for Quality and Safety (FIQS) reporting when admitted to participating inpatient study units. The text message includes an opt-out option and a prompt to receive a link by text to an online brochure explaining the FIQS study. No in-person orientation or interaction with hospital staff is provided regarding study enrollment. Enrolled participants receive daily text messages prompting them to report safety observations through the mobile-responsive FIQS survey. This arm tests whether a streamlined, text-only enrollment approach can effectively engage families and adolescent patients in safety reporting without requiring hospital staff time for recruitment

    Behavioral: Text-Only Enrollment Strategy

  • Active comparator
    Aim 1: Text Plus In-Person Enrollment

    Family members of hospitalized children and adolescent patients (\>12 y.o) receive automated text message invitations to participate in Family Input for Quality and Safety (FIQS) reporting when admitted to participating study units, plus a brief in-person orientation from hospital staff (nurses or registration team members). The text message includes an opt-out option and a prompt to receive a link by text to an online brochure explaining the FIQS study. During the admission process, hospital staff provide a standardized verbal explanation of the FIQS study using a physical brochure. Enrolled participants receive daily text messages prompting them to report safety observations through the mobile-responsive FIQS survey. This arm tests whether adding brief in-person orientation by hospital staff (with a physical brochure) improves engagement in safety reporting compared to text-only enrollment.

    Behavioral: Text Plus In-Person Enrollment Strategy

  • Active comparator
    Aim 2: Default Anonymous Reporting with Website about Impact of Program

    In a 1:1 randomized design, family members of hospitalized children and adolescent patients (\>12 y.o.) participate in Family Input for Quality and Safety (FIQS) reporting, randomized to this arm, in which their reports are shared with participating hospital units without identifiers (unless they voluntarily provide contact information). For these participants, the FIQS survey tool will link to a website showing how FIQS reports have led to hospital safety improvements. Summary reports to unit leadership are anonymized unless participants choose to provide contact information for follow-up. If contact information is provided, reports are sent immediately to unit leaders for potential service recovery. This arm tests whether maintaining participant anonymity while providing information about program impact encourages ongoing engagement with safety reporting.

    Behavioral: Anonymous Safety Reporting with Impact Website

  • Active comparator
    Aim 2: Identified Reporting without Impact information

    In a 1:1 randomized design, family members of hospitalized children and adolescent patients (\>12 y.o) participate in safety reporting where all reports are automatically shared with participating hospital units with identifiers, allowing for direct follow-up and service recovery. Participants in this arm are not directed to receive information about the impact of the FIQS program through the website or as part of the FIQS survey. All reports are sent to site investigators and safety teams with medical record numbers for potential immediate response and service recovery. This arm tests whether making reports identifiable to hospital staff increases actionability and service recovery opportunities, and how reporting without an option to remain anonymous affects participant willingness to engage in reporting safety concerns.

    Behavioral: Identified Safety Reporting

  • Other
    Aim 3: All site toolkit implementation

    Participating hospital units receive a toolkit with lessons learned from earlier collaborative safety improvement efforts and participate in a one-hour coaching session to learn how to integrate Family Input for Quality and Safety (FIQS) reports into their existing quality improvement workflows. Units choose their preferred enrollment method (text-only or text plus in-person orientation) and reporting approach (anonymous or identified) based on findings from earlier study phases. Family members of hospitalized children and adolescent patients (\>12 y.o.) use the FIQS mobile responsive safety reporting tool for 18 months while hospital teams implement toolkit recommendations to review FIQS reports, identify system-level problems, and develop safety interventions. This arm evaluates barriers and facilitators to successfully incorporating patient and family safety observations into hospital safety efforts without extensive, dedicated research infrastructure.

    Other: Safety Reporting Integration Toolkit

Interventions

  • BehavioralText-Only Enrollment Strategy

    Automated text message invitation system for safety reporting participation with online educational materials but no in-person staff interaction during enrollment process.

  • BehavioralText Plus In-Person Enrollment Strategy

    Automated text message invitation system combined with brief standardized verbal orientation provided by hospital staff during admission process using physical educational brochures.

  • BehavioralAnonymous Safety Reporting with Impact Website

    Mobile safety reporting system where reports are shared without participant identifiers, combined with access to website showing safety improvement examples to encourage continued engagement.

  • BehavioralIdentified Safety Reporting

    Mobile safety reporting system where all reports are shared with hospital staff including participant identifiers to enable direct follow-up and service recovery.

  • OtherSafety Reporting Integration Toolkit

    Implementation toolkit with lessons learned and one-hour coaching session to help hospital units integrate family safety reports into existing quality improvement workflows without research support.

06

What researchers measure

Primary outcomes

  1. Aim 1: Enrollment Opt-Out Rate

    Proportion of eligible participants who opt-out of safety reporting participation by enrollment strategy

    Time frame: 9 months

  2. Aim 2: Safety Reporting Rate

    Number of safety reports submitted per 100 patient-days by reporting strategy

    Time frame: 9 months

  3. Aim 3: Workflow Integration Success

    Number of hospital units successfully integrating safety report reviews into existing safety workflows, with at least monthly review of FIQS safety reports in existing group safety meetings.

    Time frame: 18 months

Secondary outcomes

  1. Aim 1: Enrollment Opt-Out Rate by Demographics

    Opt-out rates analyzed by participant race, ethnicity, and language preferences

    Time frame: 9 months

  2. Aim 2: Reporting Rate by Demographics

    Safety reporting rates analyzed by participant race, ethnicity, and language preferences

    Time frame: 9 months

  3. All aims: Safety Report Content Categories

    Distribution of safety report topics and categories by study arm

    Time frame: 36 months

  4. Aim 3: Safety Interventions Implemented

    Number and types of system-level safety interventions undertaken and completed in response to safety reports

    Time frame: 18 months

  5. Aim 3: Implementation Barriers and Facilitators

    Qualitative assessment of barriers and facilitators to successful integration of family safety reports into hospital safety efforts

    Time frame: 18 months

07

Study locations

8 sites
  • UCLA Mattel Children's Hospital
    Los Angeles, California 90095, United States
  • UCSF Benioff Children's Hospital - Oakland
    Oakland, California 94609, United States
  • UC Davis Children's Hospital
    Sacramento, California 95817, United States
  • UCSF Benioff Children's Hospital - San Francisco
    San Francisco, California 94158, United States
  • Texas Children's Hospital North Austin Campus
    Austin, Texas 78717, United States
  • Texas Children's Hospital The Woodlands Inpatient and Emergency
    The Woodlands, Texas 77384, United States
  • Children's Hospital of Richmond at VCU
    Richmond, Virginia 23219, United States
  • Seattle Children's Hospital
    Seattle, Washington 98105, United States
08

References and documents

Publications

  • Bardach NS, Stotts JR, Fiore DM, Sarkar U, Sharma AE, Boscardin WJ, Avina L, Peralta-Neel C, Rosenbluth G. Family Input for Quality and Safety (FIQS): Using mobile technology for in-hospital reporting from families and patients. J Hosp Med. 2022 Jun;17(6):456-465. doi: 10.1002/jhm.2777. Epub 2022 Feb 4. PubMed 35535946 ↗

Individual participant data

Plan to share: Yes — Cleaned, de-identified interview and meeting transcripts will be saved and shared. These data will be collected after obtaining informed consent. They will be shared after de-identification with relevant publications or will be posted in the repository by the end of the project period. Consent forms will include a statement that after deidentification, participant-level data will be shared and can be used for future research. Video recordings, patient-level datasets, and Epic electronic health record (EHR) code and variable names will not be shared, to protect the privacy of patients and research participants.

Supporting information: Study protocol, Informed consent form

Time frame: To facilitate interpretation of the data, data collection instruments, interview guides, and any data dictionaries created will be shared and associated with the relevant datasets. Data will be stored in common and open formats, such as Word files for our audio transcript data, and CSV files for survey data. Information needed to make use of this data along with references to the sources of those standardized names and metadata items will be included wherever applicable. Data will be available after cleaning and analysis. We anticipate a start date of Jan 1, 2030. It will be available for 5 years.

Access criteria: All dataset(s) that can be shared will be deposited in Mendeley, a generalist repository on the list of suggested generalist repositories from the NIH, listed here: https://www.nlm.nih.gov/NIHbmic/generalist_repositories.html As suggested, we will also work with journals to provide the datasets that can be shared as an online appendix for any published journal article using the data. The Mendeley repository provides metadata, persistent DOI identifiers, and long-term access. Mendeley assigns DOIs as persistent identifiers, and has a robust preservation plan to ensure long-term access. Data will be discoverable online through standard web search of the study-level metadata as well as the persistent pointer from the DOI to the dataset. We will provide the DOI in published papers and reports, in addition to progress reports to the NIH. We will keep our ORCID Records up to date with DOIs for our datasets and publications, ROR, and funder IDs to increase findability.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07871136
Responsible party
Sponsor
First posted
Oct 13, 2026
Start date
Oct 19, 2026 (estimated)
Primary completion
Sep 30, 2029 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
Oct 13, 2026

Study contacts

Naomi S Bardach, MD, MAS
Contact
Naomi.Bardach@ucsf.edu
415-476-9188
Danea M Horn, PhD
Contact
Danea.Horn@ucsf.edu
916-247-6384
Naomi Bardach, MD, MAS
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion